Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
VENT-02 by Ventus Therapeutics for Neurodegenerative Diseases: Likelihood of Approval
VENT-02 is under clinical development by Ventus Therapeutics and currently in Phase I for Neurodegenerative Diseases. According to GlobalData, Phase...
Data Insights
VENT-02 by Ventus Therapeutics for Neuroinflammation: Likelihood of Approval
VENT-02 is under clinical development by Ventus Therapeutics and currently in Phase I for Neuroinflammation. According to GlobalData, Phase I...